Long-Term Debt: The sum of all long term debt fields.
Theriva Biologics, Inc. (TOVX) had Long-Term Debt of $1.64M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-13.06M |
|
-- |
|
-- |
|
$13.13M |
|
$-13.13M |
|
$0.07M |
|
$-13.06M |
|
$-13.06M |
|
$-13.06M |
|
$-13.06M |
|
$-13.06M |
|
$-13.06M |
|
$-13.13M |
|
$-13.11M |
|
6.75M |
|
6.75M |
|
$-1.93 |
|
$-1.93 |
|
| Balance Sheet Financials | |
$14.74M |
|
$0.26M |
|
$21.09M |
|
$35.83M |
|
$12.39M |
|
|
Long-Term Debt |
$1.64M |
$12.81M |
|
$25.21M |
|
$10.62M |
|
$10.62M |
|
$10.62M |
|
9.06M |
|
| Cash Flow Statement Financials | |
$-9.47M |
|
$-0.02M |
|
$9.88M |
|
$11.71M |
|
$12.17M |
|
$0.46M |
|
$0.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.19 |
|
-- |
|
-- |
|
0.13 |
|
0.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.48M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-122.92% |
|
-122.92% |
|
-36.44% |
|
-106.49% |
|
$1.17 |
|
$-1.40 |
|
$-1.40 |
|